Elanco acquires Dutch company AHV
Elanco Animal Health announced it has closed its acquisition of AHV International, a Dutch innovator in farm animal health. The acquisition is said to offer dairy producers an expa...
Search fresh public links, source activity, and post angles for Elanco Animal Health.
Fresh curated links around Elanco Animal Health are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Elanco Animal Health announced it has closed its acquisition of AHV International, a Dutch innovator in farm animal health. The acquisition is said to offer dairy producers an expa...
Neonorm Dog extends Jaguar's existing Neonorm product franchise beyond foals and calves to provide dog owners with access to a plant-based product designed to support normal stool...
On April 20, 2026, Eli Lilly & Company (“Lilly”) and Kelonia Therapeutics, Inc. (“Kelonia”) announced an agreement for Lilly to acquire Kelonia in an all-cash transaction expec...
This animal health company, serving global livestock producers, reported a notable insider sale in its latest SEC filing.
A biomanufacturing company focused on cattle health is moving its global headquarters to the Great Plains. Axiota Animal Health recently announced it will name its Wamego, Kansas,...
May 26 2026 - Lilly to acquire three vaccine developers for nearly $4 billion admin Tue, 05/26/2026 - 11:55 Lilly keeps pushing forward with deals and pipeline mome...
Negasunt Powder and Tanidil will be available only through APHIS via National Veterinary Stockpile.
Zoetis Inc. announced that Dectomax/Dectomax®-CA1 (doramectin injection) was recently granted conditional approval of the 100 mL vial size for the prevention and treatment of infes...
A biomanufacturing company focused on cattle health solutions is relocating its global headquarters from Fort Collins, Colorado, to Wamego.
Good to know George, the PE company behind buying up the vets practices in the UK seems to be Medivet. One of our local vets has just taken on another vet who left her previous emp...
Eli Lilly is spending up to $3.8 billion to buy vaccines in development for shingles, staph infections, and Epstein-Barr virus as well as the platform technologies that spawned the...
Worth up to $2.3 billion overall, the deal hands Lilly a drug designed to address the weaknesses of a class of medicines used to treat myelofibrosis and other diseases.
Worth close to $4 billion combined, the acquisitions of Curevo, LimmaTech and Vaccine Co. signal plans by Lilly to build an infectious disease portfolio.
Eli Lilly’s run of near-weekly acquisitions still shows no sign of letting up, with the Big Pharma now buying Ajax Therapeutics for its clinical-stage myelofibrosis therapy.
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.